Current management of portal hypertension

被引：193
作者：
Bosch, J
Abraldes, JG
Groszmann, R
机构：
[1] Univ Barcelona, IDIBAPS, Hosp Clin, IMD,Liver Unit,Hepat Hemodynam Lab, E-08036 Barcelona, Spain
[2] Yale Univ, Sch Med, VA Med Ctr, Hepat Hemodynam Lab, New Haven, CT USA
[3] W Haven Univ, VA Med Ctr, Hepat Hemodynam Lab, New Haven, CT USA
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
10.1016/S0168-8278(02)00430-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S54 / S68
页数：15
相关论文
共 183 条
[1]   Propranolol for the prevention of first esophageal variceal hemorrhage:: A lifetime commitment? [J].
Abraczinskas, DR ;
Ookubo, R ;
Grace, ND ;
Groszmann, RJ ;
Bosch, J ;
Garcia-Tsao, G ;
Richardson, CR ;
Matloff, DS ;
Rodés, J ;
Conn, HO .
HEPATOLOGY, 2001, 34 (06) :1096-1102
[2]   Somatostatin and analogues in portal hypertension [J].
Abraldes, JG ;
Bosch, J .
HEPATOLOGY, 2002, 35 (06) :1305-1312
[3]   Combination of endoscopic variceal ligation and propranolol with endoscopic variceal ligation alone in the prevention of first variceal bleed: An interim analysis [J].
Agrawal, SR ;
Singh, J ;
Sharma, S ;
Sarin, SK .
JOURNAL OF HEPATOLOGY, 2002, 36 :197-197
[4]   HEMODYNAMIC-EFFECTS OF ALPHA-ADRENERGIC BLOCKADE WITH PRAZOSIN IN CIRRHOTIC-PATIENTS WITH PORTAL-HYPERTENSION [J].
ALBILLOS, A ;
LLEDO, JL ;
BANARES, R ;
ROSSI, I ;
IBORRA, J ;
CALLEJA, JL ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
HEPATOLOGY, 1994, 20 (03) :611-617
[5]   CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION [J].
ALBILLOS, A ;
LLEDO, JL ;
ROSSI, I ;
PEREZPARAMO, M ;
TABUENCA, MJ ;
BANARES, R ;
IBORRA, J ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1995, 109 (04) :1257-1265
[6]   Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension [J].
Albillos, A ;
García-Pagán, JC ;
Iborra, J ;
Bandi, JC ;
Cacho, G ;
Pérez-Paramo, M ;
Escorsell, A ;
Calleja, JL ;
Escartin, P ;
Bosch, J .
GASTROENTEROLOGY, 1998, 115 (01) :116-123
[7]   Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].
Angeli, P ;
Volpin, R ;
Gerunda, G ;
Craighero, R ;
Rone, P ;
Merenda, R ;
Amodio, P ;
Sticca, A ;
Caregaro, L ;
Maffei-Faccioli, A ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1690-1697
[8]   Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis [J].
Angelico, M ;
Carli, L ;
Piat, C ;
Gentile, S ;
Capocaccia, L .
GASTROENTEROLOGY, 1997, 113 (05) :1632-1639
[9]   Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial [J].
Avgerinos, A ;
Nevens, F ;
Raptis, S ;
Fevery, J ;
Armonis, A ;
Manolakopoulos, S ;
Poulianos, G ;
Tzathas, C ;
Katsaros, D ;
Soutos, D ;
Zacharopoulose, A ;
Adler, M ;
Bourgeois, N ;
Bac, DJ ;
VanBuuren, HR ;
Decruyenaere, J ;
Elewaut, A ;
Deman, M ;
Lepoutre, L ;
VanderSpek, P ;
Hautekeete, M ;
Reynaert, H ;
Buyse, M ;
Ritter, L ;
Burtin, B ;
Darcis, T ;
Ioannou, J ;
Natens, J ;
Natens, O .
LANCET, 1997, 350 (9090) :1495-1499
[10]   Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis [J].
Azoulay, D ;
Castaing, D ;
Majno, P ;
Saliba, F ;
Ichaï, P ;
Smail, A ;
Delvart, V ;
Danaoui, M ;
Samuel, D ;
Bismuth, H .
JOURNAL OF HEPATOLOGY, 2001, 35 (05) :590-597
12345678910